Detalles de la búsqueda
1.
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
J Pharmacol Exp Ther
; 330(1): 294-303, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19332567
2.
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
Bioorg Med Chem Lett
; 19(21): 6018-22, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19800231
3.
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510).
J Pharmacol Exp Ther
; 326(2): 672-82, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18492950
4.
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Psychopharmacology (Berl)
; 200(3): 393-401, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18594798
5.
Updated Creutzfeldt-Jakob disease infection control guidelines: sifting facts from fiction.
Med J Aust
; 199(8): 535-6, 2013 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24138376
6.
Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs.
Pharmacol Biochem Behav
; 88(3): 341-8, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17928040
7.
The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors.
Behav Brain Res
; 185(1): 32-42, 2007 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-17707919
8.
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS ß-amyloid in animal models and in Alzheimer's disease patients.
Sci Transl Med
; 8(363): 363ra150, 2016 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807285
9.
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A ß-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease.
J Med Chem
; 59(23): 10435-10450, 2016 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27933948
10.
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Psychopharmacology (Berl)
; 179(1): 207-17, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15682298
11.
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.
Pharmacol Biochem Behav
; 118: 36-45, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24211858
12.
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior.
Eur J Pharmacol
; 730: 157-63, 2014 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24602808
13.
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Eur J Pharmacol
; 728: 31-8, 2014 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486705
14.
Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease.
Parkinsons Dis
; 2012: 591094, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22191072
15.
Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination.
Pharmacol Biochem Behav
; 98(2): 181-7, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21122808
16.
The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent species.
Eur J Pharmacol
; 661(1-3): 63-71, 2011 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21545797
17.
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.
Exp Neurol
; 225(2): 384-90, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20655910
Resultados
1 -
17
de 17
1
Próxima >
>>